Filing Details
- Accession Number:
- 0001209191-23-016306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-06 16:40:06
- Reporting Period:
- 2023-03-02
- Accepted Time:
- 2023-03-06 16:40:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1358762 | Reata Pharmaceuticals Inc | RETA | Pharmaceutical Preparations (2834) | 113651945 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1903865 | Samina Khan | 5320 Legacy Drive Plano TX 75024 | Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2023-03-02 | 25,000 | $27.32 | 71,905 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2023-03-02 | 3,395 | $83.70 | 68,510 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-03-02 | 18,956 | $85.02 | 49,554 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-03-02 | 2,649 | $85.38 | 46,905 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2023-03-03 | 2,813 | $87.36 | 44,092 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Employee Stock Option (right to buy) | Disposition | 2023-03-02 | 25,000 | $0.00 | 25,000 | $27.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2032-01-03 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $83.26 to $84.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $84.26 to $85.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $85.26 to $85.58. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $87.36 to $87.41. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The options began vesting in sixteen equal installments beginning on April 3, 2022. On February 28, 2023, based on the satisfaction of certain performance criteria, the options scheduled to vest on April 3, 2025, July 3, 2025, October 3, 2025, and January 3, 2026 vested immediately. The remainder of the vesting schedule will continue as originally stated, subject to continued service through each vesting date.
Billionaire Hedge Funds
